Plain language summary of safety data on the BNT162b2 COVID-19 vaccine: development, approval and ongoing monitoring

This Plain Language Summary of Publication article (PLSP) from Expert Review of Vaccines, provides an overview of the safety of the BNT162b2 (Comirnaty^®) COVID-19 vaccine. It summarizes research on the vaccine’s development, approval, adaptation for seasonal variants, possible side effects, and ongoing safety monitoring.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data’ and was published in PubMed Central.

Visit the National Library of Medicine using the link to read the original article.

• BNT162b2
• COVID-19
• lay language summary
• plain language summary
• safety
• SARS-CoV-2
• vaccines
• variant